BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29264386)

  • 1. Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing.
    Cai ED; Kim J
    JAAD Case Rep; 2017 Nov; 3(6):539-541. PubMed ID: 29264386
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma.
    Thornton S; Coupland SE; Olohan L; Sibbring JS; Kenny JG; Hertz-Fowler C; Liu X; Haldenby S; Heimann H; Hussain R; Kipling N; Taktak A; Kalirai H
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
    Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
    Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma.
    Zhu ML; Zhou L; Sadri N
    Virchows Arch; 2018 Sep; 473(3):371-377. PubMed ID: 29926184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors.
    Mukherjee S; Ma Z; Wheeler S; Sathanoori M; Coldren C; Prescott JL; Kozyr N; Bouzyk M; Correll M; Ho H; Chandra PK; Lennon PA
    Cancer Genet; 2016 Apr; 209(4):119-29. PubMed ID: 26880400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using next-generation sequencing (NGS) platform to diagnose pathogenic germline BRCA1/2 mutations from archival tumor specimens.
    Ong PY; Poon SL; Tan KT; Putti TC; Ow SGW; Chen SJ; Chen CH; Lee SC
    Gynecol Oncol; 2019 Nov; 155(2):275-279. PubMed ID: 31481248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panel sequencing melanomas.
    Griewank KG; Schadendorf D
    J Invest Dermatol; 2015 Feb; 135(2):335-336. PubMed ID: 25573045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
    Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
    Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
    Shin S; Hwang IS; Lee ST; Choi JR
    Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput detection of clinically targetable alterations using next-generation sequencing.
    Vendrell JA; Grand D; Rouquette I; Costes V; Icher S; Selves J; Larrieux M; Barbe A; Brousset P; Solassol J
    Oncotarget; 2017 Jun; 8(25):40345-40358. PubMed ID: 28404952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
    Hintzsche JD; Gorden NT; Amato CM; Kim J; Wuensch KE; Robinson SE; Applegate AJ; Couts KL; Medina TM; Wells KR; Wisell JA; McCarter MD; Box NF; Shellman YG; Gonzalez RC; Lewis KD; Tentler JJ; Tan AC; Robinson WA
    Melanoma Res; 2017 Jun; 27(3):189-199. PubMed ID: 28296713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer.
    Lee YJ; Kim D; Kim HS; Na K; Lee JY; Nam EJ; Kim SW; Kim S; Kim YT
    Yonsei Med J; 2019 Oct; 60(10):914-923. PubMed ID: 31538426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical Implementation.
    Fernandes MGO; Jacob M; Martins N; Moura CS; Guimarães S; Reis JP; Justino A; Pina MJ; Cirnes L; Sousa C; Pinto J; Marques JA; Machado JC; Hespanhol V; Costa JL
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing of
    Park HS; Park SJ; Kim JY; Kim S; Ryu J; Sohn J; Park S; Kim GM; Hwang IS; Choi JR; Kim SI
    Ann Surg Treat Res; 2017 May; 92(5):331-339. PubMed ID: 28480178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.